What to Expect When Starting Diazepam
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Introduction
Diazepam (Valium) is a long-acting benzodiazepine used to treat anxiety, muscle spasms, acute alcohol withdrawal, and seizures (as Diastat rectal gel for emergency use). It has a long half-life (20-100 hours) with active metabolites lasting even longer, meaning effects accumulate with repeated dosing. Diazepam carries risks of sedation, dependence, and dangerous interactions with other CNS depressants.
Week-by-week timeline
Rapid Onset of Effects
Diazepam reaches peak blood levels within 30-90 minutes of an oral dose. Effects include sedation, muscle relaxation, and anxiety reduction. Because of its long half-life, drug levels accumulate over days with regular dosing. Dizziness, impaired coordination, and cognitive slowing are common, especially initially.
Accumulation Phase
With regular dosing, diazepam and its active metabolites accumulate in the body. Sedation may increase over the first week even at the same dose. Avoid driving, alcohol, and other sedating substances. Assess whether the prescribed dose is appropriate for your level of sedation.
Tolerance to Sedation
Tolerance to the sedative effect typically develops within 1-2 weeks, while therapeutic effects on anxiety or muscle spasm are maintained. Cognitive effects (memory impairment) may persist. For acute indications (alcohol withdrawal, acute muscle injury), diazepam is used short-term and tapered.
Dependence Development
Physical dependence develops predictably with regular benzodiazepine use, typically within 4-6 weeks. Have a frank conversation with your prescriber about the treatment plan and exit strategy. Diazepam should generally not be used as long-term monotherapy for anxiety.
Gradual Tapering
If discontinuing, diazepam is tapered very slowly — typically 5-10% dose reduction per week or slower. The long half-life of diazepam actually makes it useful as a taper agent for patients dependent on shorter-acting benzodiazepines, as it self-tapers more smoothly.
When to call your doctor
Contact your healthcare provider if you experience:
- Respiratory depression: slow or shallow breathing, difficulty waking (especially if combined with opioids, alcohol, or other CNS depressants — can be fatal)
- Extreme confusion or memory impairment (anterograde amnesia)
- Paradoxical reaction: increased agitation, aggression, excitement, or insomnia (more common in children and elderly)
- Severe dizziness or falls
- Worsening depression or thoughts of self-harm
- Signs of dependence: needing the medication to function normally, escalating doses without medical direction
- Allergic reaction: rash, facial swelling, difficulty breathing
Tips for getting started
Never combine diazepam with alcohol, opioids (even prescribed opioids), or other sedatives — this combination is the leading cause of benzodiazepine-related deaths. Never stop diazepam abruptly after regular use — withdrawal can cause seizures and is potentially fatal. Always taper slowly under medical guidance. Do not drive or operate machinery, especially during the first weeks. Store securely — it is a Schedule IV controlled substance. Diazepam is generally recommended for short-term use only (2-4 weeks) for anxiety.
Frequently asked questions
More about Diazepam
References
- [Regulatory] FDA Label: Valium (diazepam) Tablets https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/013263s086lbl.pdf Accessed 2026-03-01.
- [Regulatory] NIH MedlinePlus: Diazepam https://medlineplus.gov/druginfo/meds/a682047.html Accessed 2026-03-01.
- [Regulatory] FDA Black Box Warning: Benzodiazepines and CNS Depressants https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-warnings-combined-use-opioids-benzodiazepines-or-other Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: